Candel Therapeutics, Inc.CADLNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-41.77%
Near historical average
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-41.61%
Historical baseline
PeriodValue
2025-41.77%
202421.09%
2023-8.99%
2022-41.41%
2021-144.93%
2020-75.22%
20190.00%